TrialArthritis research & therapy2013

Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate.

Shankar Revu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.